Literature DB >> 9560294

Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.

H Dahmen1, U Horsten, A Küster, Y Jacques, S Minvielle, I M Kerr, G Ciliberto, G Paonessa, P C Heinrich, G Müller-Newen.   

Abstract

The transmembrane glycoprotein gp130 is involved in many cytokine-mediated cellular responses and acts therein as the signal transducing receptor subunit. Interleukin-6 (IL-6) and interleukin-11 (IL-11), in complex with their specific alpha-receptors, homodimerize gp130 and, as a consequence, activate the Janus kinase (Jak)/signal transducer and activator of transcription (STAT) signalling pathway in their target cells. So far, it is not clear whether gp130 is bound to these cytokines and their specific alpha-receptor subunits through identical or different epitopes. In order to study the interaction of IL-11 and IL-11R with human gp130 the soluble form of the recently cloned human IL-11R was expressed in baculovirus-infected insect cells. By a coprecipitation binding-assay it is demonstrated that IL-11 and IL-6 compete for binding to gp130. Using deletion and point mutants of gp130 it is shown that IL-11-IL-11R and IL-6-IL-6R recognize overlapping binding motifs on gp130. Moreover, using well-established Jak-deficient cell lines we demonstrate that STAT activation by IL-11 requires Jak1. Taken together, our data support the concept that IL-6 and IL-11 activate gp130 by very similar molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9560294      PMCID: PMC1219407          DOI: 10.1042/bj3310695

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  56 in total

1.  The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor.

Authors:  U Horsten; H Schmitz-Van de Leur; J Müllberg; P C Heinrich; S Rose-John
Journal:  FEBS Lett       Date:  1995-02-20       Impact factor: 4.124

2.  Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors.

Authors:  N Stahl; T J Farruggella; T G Boulton; Z Zhong; J E Darnell; G D Yancopoulos
Journal:  Science       Date:  1995-03-03       Impact factor: 47.728

3.  Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex.

Authors:  D Pennica; K J Shaw; T A Swanson; M W Moore; D L Shelton; K A Zioncheck; A Rosenthal; T Taga; N F Paoni; W I Wood
Journal:  J Biol Chem       Date:  1995-05-05       Impact factor: 5.157

Review 4.  Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment.

Authors:  X X Du; D A Williams
Journal:  Blood       Date:  1994-04-15       Impact factor: 22.113

5.  Interleukin-6-induced serine phosphorylation of transcription factor APRF: evidence for a role in interleukin-6 target gene induction.

Authors:  C Lütticken; P Coffer; J Yuan; C Schwartz; E Caldenhoven; C Schindler; W Kruijer; P C Heinrich; F Horn
Journal:  FEBS Lett       Date:  1995-02-27       Impact factor: 4.124

6.  Molecular cloning of two isoforms of a receptor for the human hematopoietic cytokine interleukin-11.

Authors:  M Chérel; M Sorel; B Lebeau; S Dubois; J F Moreau; R Bataille; S Minvielle; Y Jacques
Journal:  Blood       Date:  1995-10-01       Impact factor: 22.113

Review 7.  Cytokine receptor signalling.

Authors:  J N Ihle
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

8.  Two distinct and independent sites on IL-6 trigger gp 130 dimer formation and signalling.

Authors:  G Paonessa; R Graziani; A De Serio; R Savino; L Ciapponi; A Lahm; A L Salvati; C Toniatti; G Ciliberto
Journal:  EMBO J       Date:  1995-05-01       Impact factor: 11.598

9.  A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6.

Authors:  D Guschin; N Rogers; J Briscoe; B Witthuhn; D Watling; F Horn; S Pellegrini; K Yasukawa; P Heinrich; G R Stark
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

10.  Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction.

Authors:  D J Hilton; A A Hilton; A Raicevic; S Rakar; M Harrison-Smith; N M Gough; C G Begley; D Metcalf; N A Nicola; T A Willson
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

View more
  19 in total

1.  The signal transducer gp130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region.

Authors:  T Kernebeck; S Pflanz; G Müller-Newen; G Kurapkat; R M Scheek; K Dijkstra; P C Heinrich; A Wollmer; S Grzesiek; J Grötzinger
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

2.  Inactivation of IL11 signaling causes craniosynostosis, delayed tooth eruption, and supernumerary teeth.

Authors:  Pekka Nieminen; Neil V Morgan; Aimée L Fenwick; Satu Parmanen; Lotta Veistinen; Marja L Mikkola; Peter J van der Spek; Andrew Giraud; Louise Judd; Sirpa Arte; Louise A Brueton; Steven A Wall; Irene M J Mathijssen; Eamonn R Maher; Andrew O M Wilkie; Sven Kreiborg; Irma Thesleff
Journal:  Am J Hum Genet       Date:  2011-07-15       Impact factor: 11.025

3.  The binding characteristics of a cyclic nonapeptide, c(CGRRAGGSC), in LNCaP human prostate cancer cells.

Authors:  Chen Gu; Lu Liu; Yujie He; Jianwei Jiang; Zexuan Yang; Qinghua Wu
Journal:  Oncol Lett       Date:  2012-06-21       Impact factor: 2.967

4.  IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis.

Authors:  Xin Zhang; Nazanin Kiapour; Sahil Kapoor; Tabish Khan; Madhan Thamilarasan; Yazhong Tao; Stephanie Cohen; Ryan Miller; Raymond A Sobel; Silva Markovic-Plese
Journal:  J Immunol       Date:  2019-07-24       Impact factor: 5.422

5.  Negative cross-talk between interleukin-3 and interleukin-11 is mediated by suppressor of cytokine signalling-3 (SOCS-3).

Authors:  F Magrangeas; O Boisteau; S Denis; Y Jacques; S Minvielle
Journal:  Biochem J       Date:  2001-01-15       Impact factor: 3.857

6.  Bazedoxifene as a Novel GP130 Inhibitor for Pancreatic Cancer Therapy.

Authors:  Xiaojuan Wu; Yang Cao; Hui Xiao; Chenglong Li; Jiayuh Lin
Journal:  Mol Cancer Ther       Date:  2016-08-17       Impact factor: 6.261

7.  Signal transducer gp130: biochemical characterization of the three membrane-proximal extracellular domains and evaluation of their oligomerization potential.

Authors:  S Pflanz; T Kernebeck; B Giese; A Herrmann; M Pachta-Nick; J Stahl; A Wollmer; P C Heinrich; G Müller-Newen; J Grötzinger
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

8.  Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.

Authors:  C L Campbell; Z Jiang; D M Savarese; T M Savarese
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

Review 9.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.

Authors:  P C Heinrich; I Behrmann; G Müller-Newen; F Schaper; L Graeve
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

10.  IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis.

Authors:  Xin Zhang; Nazanin Kiapour; Sahil Kapoor; Joseph R Merrill; Yongjuan Xia; Woomi Ban; Stephanie M Cohen; Bentley R Midkiff; Valerie Jewells; Yen-Yu I Shih; Silva Markovic-Plese
Journal:  Clin Immunol       Date:  2018-08-24       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.